title: Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen.
abstract: The proportion of proliferating cells in non-Hodgkin's lymphomas (NHLs) as determined in situ by the expression of the Ki-67 antigen, has prognostic value in human oncology, and is strongly related to the different grades of malignancy. The evaluation of the Ki-67 index in canine NHLs may be useful in assessing the individual variability of the growth fraction in the different sub-types of lymphoma, and also the validity of the classification in terms of grade of malignancy. The growth fraction was evaluated in 92 canine NHLs, previously classified according to the Kiel classification (as adapted to the canine species), by determining the expression of the Ki-67 antigen with the MIB1 antibody on (1) paraffin-wax tissue sections in all 92 cases, and (2) fine-needle aspirates or tumour imprints in 30 cases. The labelling appeared satisfactory in 88% of the cases, with good concordance between the histological and cytological data. A highly significant correlation (P < 0.001) was established between the proportion of Ki-67+ cells and the classification into low-grade (Ki-67 index < 21%) and high-grade malignancy (Ki-67 index > 21% and usually > 29%). In the low-grade lymphoma group, a macronucleolated medium-sized-cell lymphoma not found in man had the lowest proliferation index. In the high-grade malignancy group, the number of Ki-67+ cells seemed to be proportional to cell size, whatever the phenotype, with the rare exceptions of some unclassifiable small-cell Burkitt-type or plasmacytoid lymphomas, which were highly proliferating. The classification of lymphomas into low-grade and high-grade appears to correlate well with their proliferative index. The existence of individual variations, within given categories of canine NHL, suggests that, as in human medicine, prognosis may be assisted by determining the growth fraction at initial diagnosis, and by fine-needle aspiration at relapses.
authors.affiliation: Laboratoire d'Hématologie-Cytologie-Immunopathologie, Ecole Vétérinaire de Lyon, Marcy l'Etoile Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Fournel-Fleury
authors.forename: J P
authors.initials: JP
authors.lastname: Magnol
authors.forename: L
authors.initials: L
authors.lastname: Chabanne
authors.forename: I
authors.initials: I
authors.lastname: Ghernati
authors.forename: T
authors.initials: T
authors.lastname: Marchal
authors.forename: C
authors.initials: C
authors.lastname: Bonnefond
authors.forename: P A
authors.initials: PA
authors.lastname: Bryon
authors.forename: P
authors.initials: P
authors.lastname: Felman
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002455:Cell Division; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000662:veterinary*
chemical_list: D015415:Biomarkers; D019394:Ki-67 Antigen